Your browser doesn't support javascript.
loading
Access to new drugs in paediatric oncology: can we learn from the ongoing ONC201 saga?
André, Nicolas; Buyens, Guy; Bouffet, Eric; Walker, David; Dun, Matthew D.
Afiliación
  • André N; Department of Pediatric Oncology, La Timone University Hospital of Marseille, APHM, Marseille 13005, France; SMARTc Unit, CRCM Inserm 1068- CNRS UMR 7258 Aix-Marseille University, Marseille, France. Electronic address: Nicolas.ANDRE@ap-hm.fr.
  • Buyens G; The Anticancer Fund, Brussels, Belgium.
  • Bouffet E; Division of Neuro-oncology, Department of Pediatric Hematology-Oncology, Hospital for Sick Children, Toronto, ON, Canada.
  • Walker D; University of Nottingham, Nottingham, UK.
  • Dun MD; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine & Wellbeing, University of Newcastle, Callaghan, NSW, Australia; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.
Lancet Oncol ; 24(3): 209-212, 2023 03.
Article en En | MEDLINE | ID: mdl-37052964
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Límite: Child / Humans Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Límite: Child / Humans Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article